These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder. Palomino A; González-Pinto A; Aldama A; González-Gómez C; Mosquera F; González-García G; Matute C Schizophr Res; 2007 Sep; 95(1-3):174-8. PubMed ID: 17630258 [TBL] [Abstract][Full Text] [Related]
3. [Blood phospholipids in psychoses]. Polishchuk IA; Gorodkova TM; Chernitskaia II Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(12):1828-31. PubMed ID: 4350146 [No Abstract] [Full Text] [Related]
4. Low plasma concentrations of N-methyl-d-aspartate receptor subunits as a possible biomarker for psychosis. Loureiro CM; Shuhama R; Fachim HA; Menezes PR; Del-Ben CM; Louzada-Junior P Schizophr Res; 2018 Dec; 202():55-63. PubMed ID: 29935886 [TBL] [Abstract][Full Text] [Related]
5. Serum metabolic profiling using small molecular water-soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre-post-treatment design. Cao B; Jin M; Brietzke E; McIntyre RS; Wang D; Rosenblat JD; Ragguett RM; Zhang C; Sun X; Rong C; Wang J Psychiatry Clin Neurosci; 2019 Mar; 73(3):100-108. PubMed ID: 30156046 [TBL] [Abstract][Full Text] [Related]
7. The dexamethasone suppression test in psychotic disorders. Arana GW; Barreira PJ; Cohen BM; Lipinski JF; Fogelson D Am J Psychiatry; 1983 Nov; 140(11):1521-3. PubMed ID: 6625007 [TBL] [Abstract][Full Text] [Related]
8. Disturbed endocrine function in the psychoses. I: Disordered homeostasis or disease process? Whalley LJ; Christie JE; Blackwood DH; Bennie J; Dick H; Blackburn IM; Fink G Br J Psychiatry; 1989 Oct; 155():455-61. PubMed ID: 2611570 [TBL] [Abstract][Full Text] [Related]
9. Lithium in combination with perphenazine: effect on plasma monoamine metabolites. Bowers MB; Mazure CM; Nelson JC; Jatlow PI Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190 [TBL] [Abstract][Full Text] [Related]
10. Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder. Dean B; Digney A; Sundram S; Thomas E; Scarr E Psychiatry Res; 2008 Feb; 158(1):75-8. PubMed ID: 18096247 [TBL] [Abstract][Full Text] [Related]
11. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients. Palomino A; González-Pinto A; Martinez-Cengotitabengoa M; Ruiz de Azua S; Alberich S; Mosquera F; Matute C Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():29-33. PubMed ID: 23337034 [TBL] [Abstract][Full Text] [Related]
12. Raised plasma cortisol concentrations a feature of drug-free psychotics and not specific for depression. Christie JE; Whalley LJ; Dick H; Blackwood DH; Blackburn IM; Fink G Br J Psychiatry; 1986 Jan; 148():58-65. PubMed ID: 3955320 [TBL] [Abstract][Full Text] [Related]
13. Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children. Madrid-Gambin F; Föcking M; Sabherwal S; Heurich M; English JA; O'Gorman A; Suvitaival T; Ahonen L; Cannon M; Lewis G; Mattila I; Scaife C; Madden S; Hyötyläinen T; Orešič M; Zammit S; Cagney G; Cotter DR; Brennan L Biol Psychiatry; 2019 Jul; 86(1):25-34. PubMed ID: 30878195 [TBL] [Abstract][Full Text] [Related]
14. Blood S-adenosyl-L-methionine levels in psychiatric disorders. Cohen BM; Lipinski JF; Vuckovic A; Prosser E Am J Psychiatry; 1982 Feb; 139(2):229-31. PubMed ID: 7055296 [No Abstract] [Full Text] [Related]
15. Membrane abnormalities in the psychoses and affective disorders. Hitzemann R; Hirschowitz J; Garver D J Psychiatr Res; 1984; 18(3):319-26. PubMed ID: 6492013 [TBL] [Abstract][Full Text] [Related]
16. Creatine kinase and aldolase in serum: abnormality common to acute psychoses. Meltzer H Science; 1968 Mar; 159(3821):1368-70. PubMed ID: 5644267 [TBL] [Abstract][Full Text] [Related]
17. Are oxidative stress markers useful to distinguish schizoaffective disorder from schizophrenia and bipolar disorder? Bulbul F; Virit O; Alpak G; Unal A; Bulut M; Kaya MC; Altindag A; Celik H; Savas HA Acta Neuropsychiatr; 2014 Apr; 26(2):120-4. PubMed ID: 24855890 [TBL] [Abstract][Full Text] [Related]
18. The oxidative activity of blood serum in schizophrenic and manic-depressive psychoses. WURTMAN RJ; FRANK MM; ALTSCHULE MD AMA Arch Intern Med; 1958 Nov; 102(5):790-4. PubMed ID: 13582265 [No Abstract] [Full Text] [Related]
19. On the physical properties of red cell ghost membranes in the affective disorders and psychoses. A fluorescence polarization study. Hitzemann RJ; Hirschowitz J; Garver DL J Affect Disord; 1986; 10(3):227-32. PubMed ID: 2943777 [TBL] [Abstract][Full Text] [Related]
20. Disturbed endocrine function in the psychoses. II: Discriminant function analysis of multihormone data. Whalley LJ; Christie JE; Blackwood DH; Bennie J; Dick H; Blackburn IM; Fink G Br J Psychiatry; 1989 Oct; 155():462-7. PubMed ID: 2611571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]